Chemo Fog pp 11-12 | Cite as

Patient’s Perspective

  • Robert B. Raffa
  • Kathleen J. Martin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 678)


An unknown, but significant subgroup (perhaps the majority), of patients who have undergone chemotherapy treatment for their cancer report a subsequent decline in cognitive performance (e.g., difficulty in balancing a checkbook; forgetting or mixing up names of friends or relatives, etc.). The condition has been termed chemo fog, chemo brain, or some similar term to reflect the fact that the symptoms are usually difficult to describe and involve domains of cognition such as attention, concentration, memory, speed of information processing, multitasking, or ability to organize information. The deficits are reported to persist. The magnitude of the negative impact on quality of life depends, as does the condition itself, on multiple and varied factors. This chapter relates the experience of one patient.


Subsequent Decline Cancer Report Broad Street Descriptive Phrase Comfortable Driving 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  1. 1.Department of Pharmaceutical SciencesTemple University School of PharmacyUSA
  2. 2.New HollandUSA

Personalised recommendations